Search for:
About us
Who we are
Where we operate
Sustainability & CSR
Leadership Team
Meet us / 2026 Events
Where to find us
Solutions
Full Service
Functional Service Provider
Resourcing
Centers of Excellence
Clinical Operations
Data Management
Statistics & Programming
Pharmacovigilance & Safety
Medical Affairs
eTMF Management
Regulatory Affairs
Quality Assurance
Therapeutic & Speciality Areas
Oncology & Hematology
Rare Disease & Pediatrics
Inflammation & Immunology
Infectious Disease
Pain Treatment & CNS
Late Phase & RWE
Resources
Case Studies
Blogs
Excelyate Publications
Press Releases
FAQs
Careers
EN
FR
Submit an RFP
Excelya Webinar: Are Your SDEAs Really Working in Practice?
About us
Who we are
Where we operate
Sustainability & CSR
Leadership Team
Meet us / 2026 Events
Where to find us
Solutions
Full Service
Functional Service Provider
Resourcing
Centers of Excellence
Clinical Operations
Data Management
Statistics & Programming
Pharmacovigilance & Safety
Medical Affairs
eTMF Management
Regulatory Affairs
Quality Assurance
Therapeutic & Speciality Areas
Oncology & Hematology
Rare Disease & Pediatrics
Inflammation & Immunology
Infectious Disease
Pain Treatment & CNS
Late Phase & RWE
Resources
Case Studies
Blogs
Excelyate Publications
Press Releases
FAQs
Careers
EN
FR
Search for:
Submit your request
Category
Excelyate Publications
Excelya at PV Europe 2026: Drug Safety Insights
June 8, 2026
Bayesian Methods in Clinical Trials: FDA 2026 Guidance Matters
May 20, 2026
Excelya Recap: OCT Europe 2026 Clinical Outsourcing Insights
May 12, 2026
Excelya at UBIQ Events: 5th PV & Drug Safety Conference
May 6, 2026
ACDM 2026 Recap: Key Takeaways from Excelya’s Team
April 13, 2026
Unlocking Real-World Evidence with the OMOP Data Model
April 8, 2026
Pharmaceutical Data Management: The New Role of Data Managers
March 27, 2026
Where Science Meets Psyche: Medical Monitoring in Clinical Trials
March 24, 2026
UNESCO AI Safety Conference: Key Takeaways for Healthcare and Life Sciences
March 11, 2026
Early Phase Clinical Trials: Why Safety Oversight Matters More Than Ever
March 3, 2026
1
2
3